Join Baker Donelson shareholder Matt Chester for the Celesq AttorneysEd Center Webcast "Insights from First Securities Fraud Class Action Against a Company Developing a COVID-19 Vaccine" on April 21 at 2:00 p.m.
This program will focus on heightened risk factors for publicly traded companies when providing information to investors and provide insights about such risk factors using the recent securities fraud class action filed against Inovio Pharmaceuticals Inc. and its CEO as an example. It will review the theories of securities fraud commonly relied upon, such as the fraud-on-the market theory, along with measures to avoid or limit these risks.